MDNews - Austin

++++++++++++++++++++++++ + + ++++++++++++++++++++++++ HOSPITAL ROUNDS +++ +++ NEW MATERNAL - FETAL MEDICINE SPECIALIST, PERINATOLOGIST JOINS ST. DAVID'S MEDICAL CENTER'S HIGH-RISK OBSTETRICS PROGRAM AND TRANSPORT TEAM Recently, St. David's Medical Center welcomed Linda Fonseca, M.D., perinatologist, to its team of maternal-fetal medical specialists, which supports the hospital's high-risk obstetrics program and transport team, providing lifesaving care to women and their babies throughout Central Texas. The program is designed to improve response times and outcomes for high-risk patients. Prior to joining St. David's Medical Center, Dr. Fonseca Linda Fonseca, M.D. was an assistant professor of obstetrics and gynecology in the Division of Maternal-Fetal Medicine at Northwestern University's Feinberg School of Medicine. She joined the faculty in September 2006 after completing her three-year maternal-fetal medicine fellowship at The University of Texas Medical School at Houston-Memorial Hermann Hospital. Dr. Fonseca com- pleted her obstetrics and gynecology residency at The University of Texas at Houston's Lyndon Baines Johnson General Hospital and medical school at The University of Texas at Houston. Dr. Fonseca is board certified in both obstetrics & gynecology and maternal-fetal medicine. She is a member of the American College of Obstetricians and Gynecologists, as well as the Society for Maternal-Fetal Medicine. Her interests include prenatal diagnosis of congenital anomalies, multiple gestations, second trimester pregnancy loss, management of abnormal labor, operative vaginal delivery and the effects of antenatal corticosteroids. ■ +++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++ ++++++++++++++++++++ ++++++++++++++++++++ ++++++++++++++++++++ ++++++++++++++++++++ ++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++ THAT'SNEWS VACCINES ACCORDING TO A report issued by the Institute of Medicine (IOM), a committee of experts has found no evidence linking autism or Type 1 diabetes, among few other health conditions, to vaccines. The report included a review of scientific studies regarding health outcomes associated with vaccines. The IOM says the comprehensive review will assist the Department of Health and Human Services in providing the Vaccine Injury Compensation Program (VICP), which uses scientific evidence to determine vaccine-related side effects for the eight vaccines covered by the VICP. The review revealed side effects associated with vaccinations: • MMR (measles, mumps and rubella) Not Associated With Autism or Type 1 Diabetes vaccine — Scientific evidence reveals that some people may experience seizures caused by fever in reaction to the vaccine, which was found to be temporary without long-term consequences. • Varicella (chickenpox) vaccine — Chickenpox can occur in those with a weakened immune system who receive the vaccine. In rare cases, some people will experience brain swelling, pneumonia, meningitis, shingles and hepatitis. • Anaphylaxis — This allergic reaction can occur after patients receive vaccines for hepatitis B, human papillomavirus, influenza, meningococ- cal, Varicella and tetanus-containing vaccines. It was found that MMR and diphtheria- tetanus-acellular pertussis (DTaP) were not linked to Type 1 diabetes, MMR is not a cause of autism and the influenza vaccine did not aggravate asthma nor is a cause for Bell's palsy. ■ ADVERTISERS' INDEX Brown McCarroll ....... Inside Back Cover Clinical Pathology Laboratories ...........9 Comerica Bank ......... Inside Front Cover Padgett Stratemann............ Inside Back Cover Texas Health Steps ...............Back Cover

• Cover